News

Medical News Today2h
WHO recommends lenacapavir as twice yearly injection to help prevent HIV
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
WHO recommends Gilead's twice-yearly injection for HIV prevention
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
WHO Endorses Injectable Lenacapavir As ‘Game-Changer’ In Global HIV Prevention Strategy
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
ViiV expands licence to allow generic HIV treatment production for low-income countries
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
HIV prevention gets an AI upgrade
Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...
Medscape5h
What Comes Next After Failure of Injectable HIV Medication?
After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...
News-Medical.Net on MSN10h
Many HIV-exposed newborns miss preventive treatment after birth
Newborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after ...
Bhekisisa3h
SA gets R520-million to buy the twice-a-year anti-HIV jab — but there’s a snag
SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...